ALBANY, N.Y. – July 23, 2014 – Albany College of Pharmacy and Health Sciences (ACPHS) is pleased to announce that Michael Duteau and Susan Learned have been appointed to the school’s Board of Trustees. Both Mr. Duteau and Dr. Learned are alumni of the College.
Michael Duteau, B.S., R.Ph., is Vice President of Business Development and Strategic Relations for Kinney Drugs, Inc., a retail pharmacy that operates 100 drugstores in Vermont and Central and Northern New York. He has more than 20 years of management experience specializing in pharmacy, drug store operations, patient care, and innovative business model development.
Prior to joining Kinney in 2006, Mr. Duteau was District Pharmacy Supervisor for Eckerd Corporation where he managed 80 pharmacies in Central and Eastern New York State. In addition to his responsibilities with Kinney, he has served in multiple leadership roles with pharmacy organizations at the state and national levels. He is the current president of the New York State Chain Pharmacy Association and a past Chairman (2012-13) of the New York State Board of Pharmacy. At the national level, he has been a member of the Advisory Committee on Examinations for the National Association of Boards of Pharmacy since 2005 and is a current member of the National Association of Chain Drug Stores (NACDS) National Policy Council.
Susan Learned, Pharm.D., M.D., Ph.D., is Vice President, Medicines Development Leader and Head, Psoriasis and Atopic Dermatitis Care Areas at Stiefel, a GlaxoSmithKline (GSK) company. Dr. Learned joined GSK in 1997 and spent 12 years leading various global neurosciences clinical divisions, including posts based in Europe and Asia-Pacific, before being named to her current position.
In her current role with Stiefel, Dr. Learned oversees a team of more than 100 people and is responsible for R&D of all psoriasis and atopic dermatitis assets in development, from drug candidate selection (preclinical) through launch and life cycle management. She is a member of numerous professional organizations including the American Academy of Dermatology, the Society for Investigative Dermatology, and the American Society for Clinical Pharmacology and Therapeutics. Among other appointments, she sits on the National Institute on Drug Abuse’s Medications Development Scientific Advisory Board and has been a Visiting Professor for the FDA’s Neurology and Psychiatry divisions as an advisor on the use of neuroimaging in drug development.
“We are thrilled to have Mike and Sue join the ACPHS Board of Trustees,” said Gregory Dewey, Ph.D., President of Albany College of Pharmacy and Health Sciences. “Their experiences and insights will prove invaluable in charting the strategic path for the College as it moves into the future.”
Each trustee was appointed for a three year term. According to the College’s bylaws, they may serve up to three consecutive terms as board members (i.e., nine years).
About Albany College of Pharmacy and Health Sciences
Founded in 1881, Albany College of Pharmacy and Health Sciences is a private, independent institution with a long tradition of academic and research excellence. The College is committed to educating the next generation of leaders in the health care professions and advancing innovative research that translates scientific discoveries into therapies that benefit humankind. In addition to its doctor of pharmacy program, ACPHS offers six bachelor’s programs and five graduate programs in the health sciences. The College’s main campus is located in Albany, New York; its satellite campus is in Colchester, Vermont. For more information, please visit www.acphs.edu.